A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/787 (2006.01) A61K 31/64 (2006.01) A61K 31/66 (2006.01) A61K 31/785 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2454732
It is mentioned to provide drugs for ameliorating postcibal hyperglycemia, drugs for inhibiting an increase in blood glucose level and pharmaceutical compositions for preventing or treating diabetics each containing a pharmaceutically acceptable anion exchange resin typified by colestimide. Thus, it becomes possible to provide drugs clearly exhibiting an effect of inhibiting an increase in postcibal blood glucose level.
L'invention concerne des médicaments destinés à l'amélioration de l'hyperglycémie post-prandiale, des médicaments d'inhibition d'une augmentation du niveau de glucose sanguin, et des compositions de prévention ou de traitement de personnes diabétiques, lesdits médicaments et compositions renfermant respectivement une résine d'échange d'anions acceptable pharmaceutiquement typifiée par colesmitide. Ainsi, il devient possible de produire des médicaments présentant clairement un effet inhibiteur de l'augmentation du niveau de glucose sanguin post-prandial.
Kirby Eades Gale Baker
Mitsubishi Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Drugs for ameliorating postcibal hyperglycemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs for ameliorating postcibal hyperglycemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs for ameliorating postcibal hyperglycemia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1570415